The Metabolodiuretic Promise of Sodium-Dependent Glucose Cotransporter 2 Inhibition The Search for the Sweet Spot in Heart Failure

JAMA CARDIOLOGY

AMER MEDICAL ASSOC

1. AstraZeneca
2. Boehringer Ingelheim
3. Abbvie
4. Amgen
5. Bayer
6. Bristol-Myers Squibb
7. Dalcor
8. GlaxoSmithKline
9. Merck
10. Novartis
11. Resverlogix
12. Stealth
13. Theracos
14. Sanofi-Aventis